《Commercial Times》
- 網頁服務 安克
- Sep 2
- 1 min read
Updated: Oct 28
AmCad Expands Global Reach at WDSS & World Sleep 2025
AmCad BioMed showcased its innovative sleep diagnostics technology at the World Dentofacial Sleep Society (WDSS) and World Sleep Congress in Singapore, hosting an exclusive symposium with distinguished experts including Dr. Clete Kushida (Stanford Sleep Center), Dr. Kurt Tschopp (Swiss ENT specialist), Professor Yun-zhi Chen (National Taiwan University Dental Department), and Dr. Wei-zhong Hsu (NTU Health Management Center).
CEO Yi-li Lee highlighted the company's ultrasound-based technology, AmCAD-UO, which achieves over 90% accuracy in detecting Obstructive Sleep Apnea (OSA) through quick 10-15 minute screenings. The Stanford Sleep Center showed interest in potentially incorporating the technology into insurance coverage and clinical treatment guidelines.
This third participation in the World Sleep Conference underscores AmCad BioMed's growing prominence in precision sleep health technologies and international medical innovation.